Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis
- PMID: 14675415
- DOI: 10.1046/j.1365-2141.2003.04730.x
Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis
Abstract
Flow cytometric analysis of eosin-5-maleimide (EMA) binding to red cells is a screening test for the diagnosis of hereditary spherocytosis (HS). The present study used chemical modifications to determine the integral membrane proteins that react with EMA. The predominant interaction of EMA, contributing c. 80% of fluorescence, was with the epsilon-NH2 group of lysine in band 3 protein, as previously reported. The remainder of the EMA fluorescence was attributable to labelling of accessible sulfhydryl groups on intact red cells. This reaction was heat labile. Three molecules containing sulfhydryl groups were shown to be associated with the Rh blood group protein complex by sodium dodecyl sulphate polyacrylamide gel electrophoresis. These were CD47 and the Rh-associated glycoprotein, both in the Mr 40-60 kD region, and the Rh blood group proteins in the 30-32 kD region. Immunoprecipitation, using specific monoclonal antibodies and antibody binding studies by flow cytometry, showed that the relative content of these three membrane proteins was lower in HS than normal red cells. Thus, the high predictive value of the EMA binding test for HS reflects changes in the relative amounts of the Rh-related integral membrane proteins as well as band 3 in HS red cells.
Similar articles
-
Detection of hereditary pyropoikilocytosis by the eosin-5-maleimide (EMA)-binding test is attributable to a marked reduction in EMA-reactive transmembrane proteins.Int J Lab Hematol. 2011 Apr;33(2):205-11. doi: 10.1111/j.1751-553X.2010.01270.x. Epub 2010 Nov 3. Int J Lab Hematol. 2011. PMID: 21054813
-
Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.Clin Lab Haematol. 2003 Dec;25(6):373-6. doi: 10.1046/j.0141-9854.2003.00557.x. Clin Lab Haematol. 2003. PMID: 14641141
-
Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.Cytometry B Clin Cytom. 2008 Jul;74(4):244-50. doi: 10.1002/cyto.b.20413. Cytometry B Clin Cytom. 2008. PMID: 18454487
-
Advances in laboratory diagnosis of hereditary spherocytosis.Clin Chem Lab Med. 2017 Jun 27;55(7):944-948. doi: 10.1515/cclm-2016-0738. Clin Chem Lab Med. 2017. PMID: 27837594 Review.
-
Hereditary red cell membrane disorders and laboratory diagnostic testing.Int J Lab Hematol. 2013 Jun;35(3):237-43. doi: 10.1111/ijlh.12070. Epub 2013 Mar 11. Int J Lab Hematol. 2013. PMID: 23480868 Review.
Cited by
-
Augmented erythrocyte band-3 phosphorylation in septic mice.Biochim Biophys Acta. 2007 May;1772(5):580-6. doi: 10.1016/j.bbadis.2007.02.004. Epub 2007 Feb 23. Biochim Biophys Acta. 2007. PMID: 17382523 Free PMC article.
-
[Flow cytometric test using eosin-5'-maleimide (EMA) labelling of red blood for diagnosis of hereditary spherocytosis].Zhonghua Xue Ye Xue Za Zhi. 2015 Jul;36(7):598-601. doi: 10.3760/cma.j.issn.0253-2727.2015.07.015. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 26304086 Free PMC article. Chinese.
-
Flow Cytometry as a New Accessible Method to Evaluate Diagnostic Osmotic Changes in Patients with Red Blood Cell Membrane Defects.Biomedicines. 2024 Jul 19;12(7):1607. doi: 10.3390/biomedicines12071607. Biomedicines. 2024. PMID: 39062184 Free PMC article.
-
Old and new insights into the diagnosis of hereditary spherocytosis.Ann Transl Med. 2018 Sep;6(17):339. doi: 10.21037/atm.2018.07.35. Ann Transl Med. 2018. PMID: 30306078 Free PMC article. Review.
-
Persistent red blood cells retain their ability to move in microcapillaries under high levels of oxidative stress.Commun Biol. 2022 Jul 4;5(1):659. doi: 10.1038/s42003-022-03620-5. Commun Biol. 2022. PMID: 35787676 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials